Back to Search
BRIAN MONAHAN, MD
MD
Hematology & Oncology Physician
NPI: 1912908120Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
D0035835(MD)MD039017(DC)
Research & Publications (20)
Fission yeast SWI/SNF and RSC complexes show compositional and functional differences from budding yeast.
PMID 18622392·Nat Struct Mol Biol·2008
8-other
Necrotizing enterocolitis in neutropenia and chemotherapy: a clinical update and old lessons relearned.
PMID 16836946·Curr Gastroenterol Rep·2006
6-review
Differential expression of Aspergillus nidulans ammonium permease genes is regulated by GATA transcription factor AreA.
PMID 16467464·Eukaryot Cell·2006
8-other
A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
PMID 15930350·Clin Cancer Res·2005
3-trial
Whole genome amplification from filamentous fungi using Phi29-mediated multiple displacement amplification.
PMID 15809002·Fungal Genet Biol·2005
8-other
Indole-diterpene gene cluster from Aspergillus flavus.
PMID 15528556·Appl Environ Microbiol·2004
8-other
TamA interacts with LeuB, the homologue of Saccharomyces cerevisiae Leu3p, to regulate gdhA expression in Aspergillus nidulans.
PMID 15517391·Mol Genet Genomics·2004
4-observational
Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.
PMID 14713326·Integr Cancer Ther·2003
8-other
A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin.
PMID 12955469·Cancer Chemother Pharmacol·2003
3-trial
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
PMID 12860942·J Clin Oncol·2003
3-trial
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.
PMID 12707718·Cancer Chemother Pharmacol·2003
3-trial
Isolation and characterization of two ammonium permease genes, meaA and mepA, from Aspergillus nidulans.
PMID 12455974·Eukaryot Cell·2002
7-preclinical
A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
PMID 12114415·Clin Cancer Res·2002
3-trial
Mutation and functional analysis of the Aspergillus nidulans ammonium permease MeaA and evidence for interaction with itself and MepA.
PMID 12051893·Fungal Genet Biol·2002
4-observational
Dothistroma pini, a forest pathogen, contains homologs of aflatoxin biosynthetic pathway genes.
PMID 12039746·Appl Environ Microbiol·2002
8-other
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients.
PMID 11592343·Cancer Chemother Pharmacol·2001
3-trial
Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion.
PMID 11269737·Cancer Chemother Pharmacol·2001
3-trial
Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors.
PMID 11099325·J Clin Oncol·2000
3-trial
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients.
PMID 10653882·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UNITED STATES CONGRESS H-166 US CAPITOL
WASHINGTON, DC 20515 - Phone
- (202) 225-5421
Quick Facts
- NPI
- 1912908120
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile